Drug Manufacturing and Access to Medicine in Nepal – A Literature Review of Challenges and Proposed Remediation

Author:

Bhatt Hemant,Santosh KC,Thapa Panna

Abstract

In recent years considerable attention has been paid to the issue of access to medicine. Access to medicine cannot depend on the decision of private industries only but also on government policies and strategies. According to National Health Policy2019, it is the right of all citizens to have basic health care service including access to safe, efficacious and quality medicine. Nepal is a landlocked country in South Asia. Nepal is a diverse country with a varied culture, language, and biodiversity, but generally affected by the common disease (e.g. tuberculosis, COPD, diarrhoeal disease, diabetes and malaria). There are 65 plus private pharmaceutical industries in operation in Nepal and approximately 60% of drugs are imported from India and third-world countries. The only government owned pharmaceutical industry is ‘Nepal Aushadhi Limited’ which is not fully operational in manufacturing essential medicine. Private manufacturers focus mainly on brand competition for private consumption but not in essential medicines. Some essential medicines are totally imported from India and other countries (e.g. insulin). The Nepal government has Free Drug List (FDL) consisting 70 medicines that should be provided free to the all patients but these are not accessible to all citizen of rural areas due to poor logistic management, supply chain and transportation facilities. Quality and adequacy of health services and medicines are the main problem in rural areas. This article mainly focuses on challenges of drug manufacturing and access to safe, efficacious and quality medicines in Nepal. It also emphasizes on strategies and policies being implemented to solve these problems. It is obvious that solving the challenges to provide safe, efficacious and quality medicine is collective responsibility of government of Nepal, private manufacturing industries, regulatory bodies, health professional, the patient and NGO, INGOs working on healthcare system of Nepal. Dhaka Univ. J. Pharm. Sci. 20(3): 373-379, 2022 (June) Centennial Special Issue

Publisher

Bangladesh Journals Online (JOL)

Subject

Pharmacology (medical),Pharmaceutical Science

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3